The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03035266 |
Recruitment Status :
Completed
First Posted : January 27, 2017
Last Update Posted : August 21, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Knee Injuries | Other: Blood Flow Restriction Other: Standard rehabilitation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 22 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | This is a prospective, randomized control trial. After consenting, subjects will be randomized to one of two groups by using a computer generated random number. |
Masking: | Double (Investigator, Outcomes Assessor) |
Masking Description: | Investigators recording thigh girth and isokinetic data will be blinded to group assignment. |
Primary Purpose: | Treatment |
Official Title: | The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery; A Randomized Control Trial |
Actual Study Start Date : | April 5, 2017 |
Actual Primary Completion Date : | March 12, 2020 |
Actual Study Completion Date : | March 12, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Blood Flow Restriction (BFR)
All subjects will perform traditional post-operative rehabilitation until discharge from the hospital following surgery and continue until formal discharge from physical therapy upon completion of rehabilitation. One week following surgery, subjects randomized to the BFR group will begin combining BFR with all lower extremity strengthening exercises supervised in clinic up to 3 times per week for 12 weeks.
|
Other: Blood Flow Restriction
Delfi's Personalized Tourniquet System for Blood Flow Restriction has been specifically designed to safely regulate and control tourniquet pressure. Occlusion pressures will be set at 80% of total occlusive pressure as determined by the Doppler sensor. Each subject will perform 4 sets of each exercise (1 set of 30 repetitions followed by 3 sets of 15 repetitions). The pressure will remain through completion of the final set, but not to exceed 5 minutes. One minute rest without tourniquet application will be performed between 5 minute cycles. Sets and repetitions will remain constant for each subject; however, resistance will be incrementally increased after the subject is able to complete all 75 repetitions without loss of proper form. |
Active Comparator: Standard rehabilitation (control group)
All subjects will perform traditional post-operative rehabilitation until discharge from the hospital following surgery and continue until formal discharge from physical therapy upon completion of rehabilitation.
|
Other: Standard rehabilitation
Standard of care for post-operative condition |
- Peak Torque (foot-pounds), best repetition out of 15 repetitions [ Time Frame: 12 weeks and 6 months post operative ]Change in isokinetic peak torque knee extension and knee flexion at 180 degrees/sec and at 300 degrees/second
- Thigh circumference (centimeters) [ Time Frame: baseline, 6 weeks, 12 weeks, and 6 months ]
Change in girth measurements of thigh:
10 cm from proximal patella 15 cm from proximal patella 33% length from proximal patella to inguinal crease
- Visual Analog Scale (VAS), 0 to 40 mm self report pain scale [ Time Frame: baseline, 6 weeks, 12 weeks, and 6 months ]Change in VAS for Pain
- Lower Extremity Functional Scale (LEFS) Questionnaire [ Time Frame: baseline, 6 weeks, 12 weeks, and 6 months ]Change in LEFS Outcome Measure

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Military healthcare beneficiaries between the age of 18 and 50 years.
- Must intend to remain on station at location of surgery for 6 months from date of surgery.
- Meniscus repair or cartilage restoration technique to include microfracture, osteochondral autograft transfer system, osteochondral allograft transplantation, and autologous chondrocyte implantation following standard post-operative protocol guidelines requiring a 6 week period of non-weight bearing or limited weight bearing in a brace at 0˚ degrees of extension.
Exclusion Criteria:
- Concomitant ligamentous repair/reconstruction
- Known pregnancy
- Any medical condition for which aerobic exercise is contraindicated
- Additional back, hip, or knee surgery in the previous 12 months
- History of vascular or cardiac impairment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03035266
United States, New York | |
Keller Army Community Hospital | |
West Point, New York, United States, 10996 | |
United States, North Carolina | |
Womack Army Medical Center | |
Fort Bragg, North Carolina, United States, 28310 |
Principal Investigator: | John S Mason, DSc, DPT | Keller Army Community Hospital |
Responsible Party: | John Mason, Assistant Chief, PT, Keller Army Community Hospital |
ClinicalTrials.gov Identifier: | NCT03035266 |
Other Study ID Numbers: |
16KACH016 |
First Posted: | January 27, 2017 Key Record Dates |
Last Update Posted: | August 21, 2020 |
Last Verified: | August 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
blood flow restriction strength muscle atrophy post-operative therapy knee |
Muscular Atrophy Atrophy Knee Injuries Pathological Conditions, Anatomical Leg Injuries |
Wounds and Injuries Neuromuscular Manifestations Neurologic Manifestations Nervous System Diseases |